Monoclonal antibodies (mAbs) can achieve unparalleled affinity and specificity for a wide range of biomolecules, making the reagents critical to both basic and clinical research. The vast majority ...

Six targets for multiple fragments (CD20, CD22, carcinoembryonic antigen (CEA), EpCAM, HER2/Neu and Lewis Y) are also common targets for full-length anticancer mAbs 35; for example, EpCAM has been ...

Although malaria is not common in the United States ... Anti-malarial monoclonal antibodies (mAbs) are another promising new tool that has been shown to be safe and efficacious against infection ...